About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials | 7,497 Studies Recruiting

Clinical TrialsProstate Cancer

Prostate Cancer Clinical Trials

Browse 7,497 clinical trials for prostate cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3601-3620 of 7,497 trials

CompletedProspective CiRculating prOstate Cancer Predictors in HighEr Risk mCRPC studYThis study will develop a first-in-man CTC-based molecular taxonomy of CRPC in the context of novel AR-directed therapies, categorize different patterns of resistance in this…NCT02269982·Chicago, Illinois and 4 others CompletedIS-002 Phase 2 Prostate Cancer StudyPhase 2 randomized controlled multi-center study of IS-002, in conjunction with near-infrared (NIR) fluorescence imaging, for identification of prostate cancer during…NCT05946603·San Francisco, California and 3 others UnknownWalking Football as a Supportive Medicine for Patients With Prostate CancerAndrogen deprivation therapy (ADT) is widely used in men with prostate cancer (PCa) to delay disease progression and enhance survival.NCT04062162·Vila Nova de Gaia

Related Searches

prostate carcinomatrials

Data from ClinicalTrials.govTerms

TerminatedPre-Prostatectomy Celecoxib or PlaceboThis study will seek to determine if the downstream effects of cyclooxygenase-2 (COX-2) inhibition suggested by preclinical systems occur in human prostate cancer.NCT02840162·Portland, Oregon and 1 other

CompletedImproving Outcomes in Cancer Patients on Oral Anti-Cancer Medications Using a Multi-modal Mobile Health InterventionThis study evaluates a smart phone based mobile application designed for patients with Renal Cell and Prostate Cancer taking oral anti-cancer medications.NCT02375776·Boston, Massachusetts

Not yet recruitingA Dose Optimization Study of Enzalutamide in Elderly Patients With Advanced Prostate CancerThis is a phase II, single-centre, pragmatic, non-randomized, dose escalation study to evaluate optimal dose levels of enzalutamide in elderly patients using pharmacokinetic blood…NCT07512076·Toronto, Ontario

TerminatedDiet and Exercise Program to Promote Weight Loss and Improve Health in Men With Low- or Low-Intermediate-Risk Prostate CancerThis randomized phase III trial studies a diet and exercise program based on the Diabetes Prevention Program to promote weight loss and improve health in men with low-risk or…NCT02454517·Seattle, Washington

CompletedDocetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone TherapyRATIONALE: Drugs used in chemotherapy, such as docetaxel and prednisolone, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping…NCT00554918·Birmingham, England and 15 others

UnknownRetzius-sparing Technique in Robotic-assisted Radical ProstatectomyThe objective of this study is to compare the short-term and 1-yr follow-up functional outcomes of retzius-repairing robot-assisted radical prostatectomy (RR-RARP) with…NCT05224024·Ankara, Altındag

CompletedAxitinib Before Surgery in Treating Patients With High-Risk Prostate CancerThis randomized phase II trial studies how well axitinib works in treating patients with high-risk prostate cancer before undergoing surgery.NCT01385059·Duarte, California

RecruitingBuilding on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource SpotsTo evaluate a community-based outreach initiative for screening, diagnosis, and treatment of breast, lung, and prostate cancers in underserved adults using the Reach…NCT07231159·Orlando, Florida

RecruitingEvaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans AffairsThe objective of the pragmatic trial to test the effectiveness of an existing, ongoing clinical service, the VA National TeleOncology program (NTO), a multilevel telehealth…NCT06559059·Brooklyn, New York and 4 others

UnknownA Phase III Intensity Radiotherapy Dose Escalation for Prostate Cancer Using HypofractionationThe goal of this clinical research study is to compare using external beam radiotherapy with intensity modulated beams for fewer days at a higher dose per day to the same type of…NCT00667888·Houston, Texas

CompletedPRO-STATE:Search for a Protein Profile Corresponding to Fast-developing Lesions and Characterization of Implicated Proteins in Prostate CarcinomaThe main objective of this study is to realise serum protein profiles for each patient undergoing a prostate biopsy and to identify relevant proteins.NCT00427817·Grenoble

TerminatedAbemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial TreatmentThe main purpose of this study is to learn more about the safety and tolerability of abemaciclib when given in combination with darolutamide to participants with prostate cancer…NCT05999968·Springdale, Arkansas and 12 others

CompletedCombination Iodine 125 Seed Implants and LHRH Agonists for Locally Advanced (Stage T3) Prostate CancerPatients with prostate cancer should have the following examination including biopsy, serum PSA volume, prostate CT scan or MRI, bone scan, abdomen ultrasound, chest X ray, blood…NCT01813097

WithdrawnDose-Finding Study of Afuresertib Administered in Combination With Either Enzalutamide or AibrateroneThis study is being conducted to characterize the safety and recommended phase 2 dose (RP2D) of combining afuresertib, independently with 2 approved drugs: enzalutamide (Xtandi®…NCT02380313

CompletedMarkers for Early Detection of Prostate CancerThis study will determine whether certain gene alterations can serve as markers for early detection of prostate cancer.NCT00340717·Tacoma, Washington

CompletedSingle Fraction Early Prostate Irradiation (SiFEPI)Recently, HDR brachytherapy delivering only a 19 Gy fraction was proposed as exclusive treatment for low and intermediate risk prostate cancers.NCT02104362·Nice

CompletedStudy of Cabozantinib (XL184) in Adults With Advanced MalignanciesThis is a Phase 2 study to evaluate the efficacy and safety of cabozantinib (XL184) in subjects with selected advanced tumor types.NCT00940225·Scottsdale, Arizona and 46 others

PreviousPage 181 of 375Next